TentaConsult takes over former i.DRAS
Münster/Munich 11 July 2023 - TentaConsult Pharma & Med GmbH is growing at a high level: the Münster-based company has now merged with the former i.DRAS GmbH from Munich. All locations will continue to exist after the merger.
The company based in Münster, Munich and Bordeaux (FR) offers strategic consulting and services for pharmaceutical products and takes on regulatory tasks and responsibilities on behalf of clients. "As an internationally active consulting firm for pharmaceuticals and medical devices, we are happy to fully welcome the experienced regulatory services specialists in Munich to our team," explains Ralf Sibbing, Managing Partner of TentaConsult GmbH.
"Our colleagues work together in partnership in international, project-based teams. With the combined capacities of all three locations, we have an excellent team that is professionally engaged at the highest level, both in an advisory and executive capacity for our clients," Ralf Sibbing is pleased to say.
The former i.Dras GmbH used to be on the market under the name HWI-Regulatory Services GmbH. This was taken over by TentaConsult - a company of the Tentamus Group - in 2022 and initially operated under the name TentaConsult Regulatory Services GmbH. Since 06 July 2023 it has now been fully merged with the pharmaceutical consulting company TentaConsult Pharma & Med.
Contact:
TentaConsult Pharma & Med GmbH
Wienburgstraße 207
48159 Münster
Contact person:
Ralf Sibbing (Managing Partner)
Tel.: +49 (0) 251 928 715 60
ralf.sibbing@tentaconsult.com
www.tentaconsult.com